טוען...
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
OBJECTIVE: To compare the cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in patients with atrial fibrillation (AF). METHODS: Using standard methods, we created a Markov decision model based on the estimated cost of apixaban and data from the Apixaban for Reduction in Stro...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Lippincott Williams & Wilkins
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3525294/ https://ncbi.nlm.nih.gov/pubmed/22993279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31826d5fe8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|